The potential role of D(2) dopamine receptors as a target in the management of neuroendocrine tumors.
Dopamine is considered to be the main catecholamine neurotransmitter in the human central nervous system where it controls a variety of functions (cognition, emotion, hunger and satiety, locomotor activity) in addition to endocrine system regulation. Dopamine also plays multiple roles in the periphe...
Main Authors: | Ribeiro-Oliveira, A, Korbonits, M, Grossman, AB |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2008
|
Similar Items
-
The role of somatostatin analogues in the treatment of neuroendocrine tumours.
by: Grozinsky-Glasberg, S, et al.
Published: (2008) -
Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
by: Korbonits, M, et al.
Published: (1998) -
The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors.
by: Korbonits, M, et al.
Published: (2001) -
Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms.
by: Grozinsky-Glasberg, S, et al.
Published: (2008) -
The role of chemotherapy management of malignant in the nonsurgical neuroendocrine tumours
by: Kaltsas, G, et al.
Published: (2001)